| dbo:abstract
|
- OrbusNeich (/ˌɔːrbəsˈniːʃ/ or-bəs-NEESH) is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. In 2013, OrbusNeich received CE mark for the world's first and only dual therapy stent, the COMBO Dual Therapy Stent. The COMBO Stent features active endothelial progenitor cell (EPC) capture technology, which promotes the accelerated natural healing of the vessel wall after the implantation of a stent. Several trials including a randomized study dedicated to patients with Acute Coronary Syndrome (ACS) and registries with a sizeable ACS patient subset demonstrated consistently low event rates and short DAPT option of 3 months, if needed. (en)
|
| dbo:foundingYear
| |
| dbo:headquarter
| |
| dbo:industry
| |
| dbo:numberOfEmployees
|
- 500 (xsd:nonNegativeInteger)
|
| dbo:product
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 5784 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founded
| |
| dbp:homepage
| |
| dbp:hqLocation
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Teddy Chien , David Chien , Denise Lau (en)
|
| dbp:logo
|
- ON Logo with Tagline.jpg (en)
|
| dbp:name
| |
| dbp:numEmployees
| |
| dbp:products
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- OrbusNeich (/ˌɔːrbəsˈniːʃ/ or-bəs-NEESH) is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
